Impact of CYP2D6*4 genotype on progression free survival in tamoxifen breast cancer treatment

Author: Stingl Julia Carolin   Parmar Sumit   Huber-Wechselberger Ariana   Kainz Alexander   Renner Wilfried   Seeringer Angela   Brockmöller Jürgen   Langsenlehner Uwe   Krippl Peter   Haschke-Becher Elisabeth  

Publisher: Informa Healthcare

ISSN: 1473-4877

Source: Current Medical Research and Opinion, Vol.26, Iss.11, 2010-11, pp. : 2535-2542

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content